Modifiable and emerging risk factors for type 2 diabetes in Africa: a systematic review and meta-analysis protocol by Issaka, Ayuba et al.
 DRO  
Deakin Research Online, 
Deakin University’s Research Repository  Deakin University CRICOS Provider Code: 00113B 
Modifiable and emerging risk factors for type 2 diabetes in Africa: a 
systematic review and meta-analysis protocol 
Citation:  
Issaka, Ayuba, Paradies, Yin and Stevenson, Christopher 2018, Modifiable and emerging risk 
factors for type 2 diabetes in Africa: a systematic review and meta-analysis protocol, 
Systematic reviews, vol. 7: 139, pp. 1-10. 
DOI: http://www.dx.doi.org/10.1186/s13643-018-0801-y 
 
 
 
 
© 2018, The Authors 
Reproduced by Deakin University under the terms of the Creative Commons Attribution Licence 
 
 
 
 
 
 
Downloaded from DRO:  
http://hdl.handle.net/10536/DRO/DU:30114031 
PROTOCOL Open Access
Modifiable and emerging risk factors for
type 2 diabetes in Africa: a systematic
review and meta-analysis protocol
Ayuba Issaka1* , Yin Paradies2 and Christopher Stevenson1
Abstract
Background: Type 2 diabetes mellitus (T2DM) remains a public health problem in low-income countries, including
African countries. Risk factors of this disease in Africa are still unclear. This study will examine the modifiable and
emerging risk factors associated with T2DM in Africa.
Methodology: The study will include a systematic review and meta-analysis of published and unpublished
empirical studies, reporting quantitative data only. We will conduct a search on scientific databases (e.g. Global
Health), general online search engines (e.g. Google Scholar) and key websites for grey literature using a
combination of key countries/geographic terms, risk factors (e.g. overweight/obesity) and T2DM (including a
manual search of the included reference lists). We will use the Comprehensive Meta-Analysis Software (CMA)
version 2.0 for data management and analysis. This protocol follows the Preferred Reporting Items for Systematic
Review and Meta-Analysis Protocols (PRISMA-P).
Discussion: The systematic review and meta-analysis will provide a robust and reliable evidence base for policy
makers and future research. This may help with identifying and implementing more cost-effective diabetes
prevention strategies and improved resource allocation.
Systematic review registration: This protocol has been registered with the PROSPERO international prospective
register of systematic reviews. The reference number is CRD42016043027.
Keywords: Type 2 diabetes, Modifiable risk factors, Africa, Meta-analysis, Association
Background
Once described as a disease of the affluent, type 2 dia-
betes mellitus (T2DM) has emerged as a significant
non-communicable disease (NCD) that is threatening
the economic, social and cultural fabric of African popu-
lations [1]. High diabetes prevalence is driven by eco-
nomic expansion, urbanisation, lifestyle choices and
ageing [2, 3], with significant variation from one geo-
graphical region to the other [4]. The regions include
countries of the same or different lingua franca (e.g.
Francophone vs. Anglophone countries), as well as
urban and rural areas [5, 6]. Despite the paucity of data,
Africa is set to bear the most significant T2DM
epidemiological burden including its complications and
mortality in the coming decades [7, 8]. By 2045,
Sub-Saharan Africa (SSA) alone is projected to experi-
ence an approximately 156% increase in diabetes preva-
lence compared to 48% of the world [3].
According to the global burden of disease study, NCDs
including diabetes contribute yearly to more than 60% of
the global mortality, 80% of death, as well as 54% of glo-
bal disability-adjusted life years (DALY) lost [1, 9, 10].
Of these, 90% of preventable death and 80% of early
death occur in developing countries including the Afri-
can region [1, 10]. In Africa, the burden of diabetes and
other NCDs such as heart diseases are expected to
eclipse that of communicable disease by 2025 in terms
of associated mortality and morbidity [6, 11, 12]. Yet,
communicable diseases attract the most political atten-
tion and resource allocation [13–15]. While this double
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burden of disease is evident, Africa does not have the re-
sources and infrastructure to deal with the growing bur-
den of diabetes, in addition to existing communicable
diseases [15]. This double burden of disease culminates in
a cascade of challenges faced by policy makers, health pro-
fessionals and funders alike, with significant preventative
medicine and public health dimensions. Additionally,
69.2% of the population aged 20 to 79 years not only are
undiagnosed and unaware of its complications in SSA
alone [3] but also unable to access the correct educations
and health services [16]. Consequently, the majority of pa-
tients are diagnosed after presenting complications.
While knowledge of diabetes risk factors is important
to positively shift population distributions, no systematic
review and meta-analysis, to our knowledge, has exam-
ined the strength of associations between these risk fac-
tors and T2DM in Africa as well as the role of urban
and rural areas. Identifying the most important diabetes
risk factors may (1) influence policies and improve the
allocation of resources and (2) substantially halt diabetes
incidence, increase health gains and prevent loss of
productivity due to complications and premature death
[1, 17]. However, since we cannot affect T2DM derived
from non-modifiable risk factors such as family history,
sex and age [18, 19], the study considers modifiable risk
factors within the African context and aims to conduct a
systematic review and meta-analyses of all available pub-
lished data and qualified studies that have examined
these risk factors and T2DM in Africa.
Review of diabetes modifiable risk factors: the
African context
Despite a significant paucity of empirical data in Africa,
some advances in diabetes risk factor studies have been
made. Yet, apart from genetic factors and predisposi-
tions of diabetes in Africa [20], diabetes natural history,
as well as its clinical significance are poorly understood
[20, 21]. This is likely due to the fact that the majority of
the risk factor studies have been conducted within West-
ern countries [21, 22]. As such, researchers still remain
somewhat unsure as to what extent much of the existing
knowledge applies to Africa [21]. For modifiable risk fac-
tors, the broader determinants such as social, cultural,
environmental and economic influences are likely to be
Africa-specific [21]. Here, we discuss these specific risk
factors with respect to T2DM, and they include diet, to-
bacco, alcohol, physical inactivity, and adiposity [6, 14].
Diet
Around the globe, the epidemics of adiposity (e.g. over-
weight/obesity) and T2DM are mainly driven by the
quality of diet and disproportionate caloric consumption
[23]. Evidence suggests that independent of BMI, fat
quality and carbohydrates are important predictors of
diabetes [24]. For example, while glycaemic load and
trans fat are strongly associated with increased risk of
diabetes [23], higher consumption of high-fibre diet in-
cluding fruits and vegetables are associated with de-
creased diabetes risk. This is exemplified in a
meta-analysis that suggests that two servings of whole
grain per day is associated with a 21% lower risk of dia-
betes [25]. In Africa, studies on dietary patterns con-
ducted in urban Ghana by Frank et al. [26] showed
inadequate fruit and vegetable consumptions association
with increased risk of T2DM. These findings are con-
cordant with Ekpenyong et al.’s [27] study among Niger-
ian population and also reported in Sack et al.’s [7] study
among a Senegalese population. In North Africa coun-
tries such as Egypt, key diets are mainly rich in high gly-
caemic load and high glycaemic index, including white
bread and polished rice [28]. The high intake of trans
fat is now evident in Africa countries. Egypt is now
among the world highest consumers of these unhealthy
fats [28].
In Africa, due to food market globalisation, multi-
national fast food chains have multiplied substantially,
contributing to the transition from a high-fibre diet to
an energy-dense westernised diet [29, 30]. For example,
within SSA alone, fast food outlets have increased from
zero in 1980 to the current figure of more than 1000
Kentucky Fried Chicken outlets [1, 31]. There are now
about 900,000 retail Coca-Cola outlets across SSA alone,
with approximately 78 million servings consumed daily
[1, 32]. Independent of BMI, consumption of
sugar-sweetened beverages increases the risk of T2DM
[23]. The most recent meta-analysis showed that sub-
jects who consume one to two servings of
sugar-sweetened beverages per day fall in the higher
quartile and have 26% greater risk of diabetes than those
in the lower quartile [23, 29]. Further, studies suggest
that a 1% rise in sugar-sweetened beverages contributes
to an additional 4.8% overweight, 2.3% obese and 0.3%
diabetic adults [33].
In many Africa countries, fruit and vegetable availabil-
ity are seasonal. As such, most African’s fruit and vege-
table consumptions are not incorporated into normal
daily food routines [34]. While the food market global-
isation has the propensity to boost the availability of
fruit and vegetables, easy access is strongly associated
with higher socioeconomic positions in most countries
and ultimately determines their intake [35].
Tobacco
Tobacco use (either smoked or smokeless) has a strong
relationship with T2DM, either as an independent risk
factor or in clusters with other risk factors such as
centripetal obesity [36, 37]. Smokeless tobacco products
are the leaves of a plant called Nicotiana tabacum [38,
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39], which are considerably cheaper than cigarettes [40]
and used more by people of low socioeconomic status.
The product is consumed as a smoke, a chew or a snuff.
A meta-analysis by Willi et al. [41] shows that smokers
have a 45% increased risk of diabetes compared with
non-smokers. Smoking is very common among men in
both SSA and North Africa including Tunisia and Libya.
In Egypt, approximately, 39.7% of adult males are
smokers [28]. In Africa, despite a paucity of data on
smokeless tobacco toxicities, studies that do exist show
that traditionally made smokeless tobacco has higher
carcinogenic tobacco-specific nitrosamines than com-
mercially made cigarettes smoking [39, 42]. In South Af-
rican studies, women who are heavy smokers showed
increased diabetes risk [39].
Prevalence of smokeless tobacco use among children
aged between 13 and 15 years, in some African countries
between 2007 and 2009, was 4.6% (boys 4.6%; girls 4.3%)
in Tanzania (Dares Salaam), 22.2% (boys 18.9%; girls
24.5%) in rural Sierra Leone, 20.8% in Democratic Re-
public of Congo (Kinshasa), 21.9% in Gambia (Banjul)
and 5.1% (boys 5.4%; girls 4.4%) in Cameroon (Yaounde)
[39, 43]. The use of smokeless tobacco is widespread, yet
under-researched [44]. Due to the globalisation of the
tobacco industry’s influence [40, 45] and the persistently
low level of health literacy, tobacco prevalence (both
smoked or smokeless) is expected to reach pandemic
proportions in Africa within the next decade [40, 46].
Alcohol
Alcohol use is a major contributor to premature death
and disability [47]. A systematic review by Howard et al.
[48] found moderate alcohol consumption is associated
with a decreased incidence of T2DM. Alcohol abuse
vastly increases adiposity and abdominal obesity among
all sexes [48]. Studies conducted in Nigeria [49], Kenya
[50], South Africa [51] and other African countries [16]
found varied correlations between alcohol consumption
and diabetes. Others have shown alcohol abuse to be
strongly linked to diabetes incidence [52]. These findings
have been reported among different population groups
in Africa, including rural South Africa [53], Kenya [54]
and Nigeria [52, 55].
Alcohol use is high in Africa, except in countries
where it is prohibited. In many African countries, alco-
hol is central to the cultures, traditions, customs and so-
cial life, with long-standing historical significance [56,
57]. Western spirits, although expensive, are culturally
and economically important due to their status [58].
Western spirits are chiefly reserved for traditional drink-
ing events and major occasions [59]. However, locally
produced alcohol is common and cheaper and is most
preferred [58, 59]. It is widely consumed both in rural
areas and poor urban cities [60] and includes fermented
beverages like ogogoro in Nigeria, burukutu and pito or
ginlike (mainly illicit) in Zambia and Ghana or gongo in
Tanzania [58]. Despite the growing interest in alcohol
use in Africa, little is known about the patterns and
levels of consumption among these populations [59]. Ex-
acerbating the effect of alcohol use is the evolution of
globalisation, acculturation and urbanisation of alcohol
consumption in Africa [6], including increased ease of
access [30].
Physical inactivity
Physical activity is the major determinant of energy ex-
penditure—a significant factor in energy balance and
weight control [61]. According to WHO 2010, moderate
physical activity (approximately 150 min per week) re-
duces the risk of diabetes by 27%, colon cancer by 21–
25% and ischemic heart disease by 30% [61]. In Africa,
studies presenting findings on physical inactivity are well
documented. They include Nyenwe et al.’s [52] study
among Port Harcourt, Nigeria populations in which
physical inactivity was significantly associated with
higher prevalence of T2DM. This finding is also re-
ported by Sack et al. [7], Motala et al. [53], Assay et al.
[62] and Christensen et al. [54]. Various studies con-
ducted in SSA including Ouagadougou (Burkina Faso)
[63], Cameroon [64], South Africa [65] and West Africa
[66] have all linked physical inactivity to the rising bur-
den of diabetes.
From a cultural perspective, structured or deliberate
physical activity in most African countries is not usually
viewed as a health-related risk factor but mainly through
the lens of sports [67]. Additionally, in most countries
particularly in North Africa, such as Egypt, exercise is
avoided in public places, representing a significant factor
in reduced physical activities [28]. There is also a scar-
city of exercise facilities in Africa, and those that exist
are very expensive [28]. In addition, the link between
vitamin D deficiency and increased risk of diabetes is
evident [68]. However, exposure to vitamin D via sun-
light is reduced by traditional female clothing mainly
among women of Islamic faith in many areas of Africa.
Furthermore, while physical activity is obtained from
its occupational (e.g. manual labour and farming) or in-
cidental use (e.g. walking) in most countries, the growing
use of mechanisation is evident in growing urbanisation
[16]. While driving in industrialised countries has largely
displaced physical activity (e.g. walking and manual
labour), this phenomenon is also now evident in most
African countries [16, 23], particularly in cities. In cities,
the growing use of technologies such as mobile phones
and prolonged viewing of television further contributes
to the decline in physical activity. As a result, the inci-
dental and occupational physical activities which were
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once used to offset the glycaemic load and trans-fat are
diminishing [23].
Adiposity (obesity)
Historically, being overweight was once rare in Africa,
due to food scarcity and high-energy expenditure [12].
However, as a result of economic, social, cultural, psy-
chological and biological influences, obesity has soared
[69]. Higher prevalence is marked by urbanisation and
economic expansion [6]. For example, countries with ad-
vanced economies [70], including South Africa and
Seychelles, have higher obesity prevalence [1, 6]. Gender
differences in obesity prevalence are also evident. Studies
conducted in other parts of Africa such as rural parts of
Cameroon showed that, over a 10-year period, obesity
increased by 84% and 54% among men and women re-
spectively [71]. Obesity among men ranges from 12%
and 13.8% in Ethiopia [72] and Cameroon [71] and
among women 10.8% to 34% in Ethiopia [73] and Ghana
[74], respectively. In addition, from a socio-cultural per-
spective, obesity is revered. This notion is rooted in the
fundamental beliefs and traditional orientations that in-
fluence people’s perceptions and attitudes towards large
body size. As a consequence, in much of Africa, being
overweight is not considered as a risk factor but rather a
sign of high socio-economic standing and beauty [75].
In Africa, numerous studies presenting findings on
various parameters of adiposity such as obesity, over-
weight, abdominal obesity, BMI and waist-to-hip ratio
are marked. For example, in Motala et al.’s [53] study of
1025 subjects (815 women) among the rural South Afri-
can population, the multivariate analysis shows that the
significant independent risk factors associated with dia-
betes include waist circumference (odds ratio 1.1) and
hip circumference (0.9) for both men and women. These
findings are in direct agreement with other studies in
the African region [76–80]. Similarly, in Isara and Okun-
dia’s [81] study among adult residents of rural communi-
ties in southern Nigeria, overweight/obesity (OR = 3.53)
was significantly associated with diabetes. Kari et al. [82]
also found that diabetes was associated with overweight/
obesity (OR = 3.02/4.43). Among a Senegalese popula-
tion, Sack et al. [7] found that abdominal obesity (OR =
1.17, p = 0.05) was strongly associated with diabetes.
Similar findings have been reported in populations of
South Nigeria [27], South Africa [83] and Tanzania [22].
The association between BMI and diabetes in different
parts of Africa was also evident in studies conducted in
Nigeria [52], South Nigeria [27], South Africa [53] and
Sudan [77].
Psychosocial factors
Several studies have identified psychosocial factors (e.g.
stress, depression, anxiety) as emerging risk factors for
diabetes and NCDs [6, 14, 23, 84]. Stress is a major con-
tributing factor in metabolic syndrome [85]. Stress not
only increases the risk of developing T2DM but also in-
creases the risk of other cardiovascular diseases [86, 87].
A systematic review and meta-analysis by Chida and
Hamer [88] found a detrimental association between ad-
verse psychosocial factors and the prognosis of diabetes.
A study among South Africa women, on psychosocial
factors, found that stress was strongly associated with
diabetes [88]. Multiple studies conducted in Africa have
associated stress to cardiovascular diseases [14]. In Af-
rica, little data exist on rates of depression and its corre-
lates; however, its effects must not be discounted in
efforts to curb diabetes incidents.
In sum, while waiting for more empirical data and
studies on diabetes risk factors to become available,
existing and accessible studies may be an effective re-
source in understanding the contribution of these risk
factors and burden of diabetes in Africa.
Rational
In Africa, despite the primary epidemiological studies pre-
sented above, to date, no studies to our knowledge have
systematically meta-analysed these findings. It is impera-
tive to note, though, that ample reviews [12, 18, 89, 90]
exist, including a limited number of meta-analysis [91, 92]
predominantly focused on the epidemiological burden of
diabetes (e.g. prevalence, incidence, complications, DALY
and economics) and their outcomes (mortality and mor-
bidity) [1, 8, 15, 16, 18, 20, 22, 28, 67, 89, 92–94]. The
present systematic review and meta-analysis will endeav-
our to fill this gap, generate new hypothesis and attempt
to promote a renewed attention to the role of contempor-
ary diabetes modifiable risk factors in Africa.
Research aim
The aim of this systematic review and meta-analysis is
to assess the association between modifiable risk factors
and T2DM in Africa.
Objectives
(1) To assess the magnitudes of associations between
modifiable risk factors (obesity, physical activity,
tobacco, smoking, fruit and vegetable consumption,
psychosocial factors (e.g. stress, anxiety) and T2DM
in African countries)
(2) To use ranking to assess which risk factors have the
strongest association with T2DM in Africa
(3) To examine the impact of the following moderators
on associations between modifiable risk factors and
diabetes: study setting (rural/urban) and study
country language (Anglophone/Francophone)
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Hypotheses
Guided by the findings of previous meta-analysis and
systematic reviews, the hypotheses of this study include:
(1) Studies on modifiable risk (obesity, BMI, physical
inactivity, fruit and vegetable consumption) and
their strength of associations with T2DM as an
outcome will be limited.
(2) Studies on tobacco consumption including
smokeless tobacco and its association with T2DM
will be the most limited.
(3) Diabetes risk factors such as obesity and physical
inactivity will be the major risk factors. Obesity will
be most strongly associated with T2DM compared
with other modifiable risk factors.
(4) Moderators such as urban settings will have a
significant influence on diabetes risk factors and T2DM.
(5) Relationships between risk factors and T2DM may
differ between Africa and developed countries.
(6) The most important risk factor causing most burdens
may differ between Africa and developed countries.
Methods and design
Design
The study will comprise a systematic review and
meta-analysis. The study will follow the reporting guide-
lines and criteria set in Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analysis Protocols (PRISMA-P)
(Table 1).
Heterogeneity in measured outcomes
The literature from this area suggests that an amount of
heterogeneity may exist, such as differences in methodo-
logical approaches making study comparison difficult,
and some may lack clear case definitions, standard diag-
nostic criteria or control groups to evaluate potential
study biases [6]. Most physical inactivity studies may use
self-report questionnaires that are not validated [64, 95],
while others may use locally validated self-reported ques-
tionnaires [67, 83, 96]. As a result, variations of the effect
in both primary and secondary outcomes are possible.
Primary outcomes
The study will provide a summary of pooled measure of
association between one or more risk factors and T2DM
and rank them accordingly.
Secondary outcome
The study will provide more reliable evidence in the un-
derstanding of the contemporary diabetes modifiable
risk factor associations with T2DM in Africa.
Database searches
Health and biomedical
 CINAHL, MEDLINE, PsycINFO, Psychology and
Behavioural Science, Global Health and Embase
Grey literature
 Dissertation of Thesis
 Conferences
 BIOSIS Previews, Embase, MEDLINE, CINAHL
Plus, Grey Literature reports, PsycEXTRA,
OpenGrey, WorldWideScience, World Health
Organization
 International Diabetes Federation, African Journal
Online, African Development Bank, UNICEF and
USAID database
Multidisciplinary
 Scopus and Academic Onefile
Internet search engines
 Google, Google Scholar, research centres in Africa
and university websites
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
• Only empirical research from
published and grey literature that
have examined modifiable risk
factors with T2DM as an outcome
measure will be included in this
study.
• All studies published from 2000 to
16 November 2017 will be
included to coincide with the
Millennium Development Goals
(MDG) launch. Also, since the
WHO diagnostic criteria for
diabetes was widely accepted
from 1998 [18, 90] and revised in
1999, studies conducted earlier
may have used different criteria
for diabetes diagnosis [95].
• Only studies reporting
quantitative data will be included.
These may include cross-sectional,
cohort, longitudinal and case-
control studies.
• Studies will be included, if fasting
blood plasma (FPG) and oral
glucose tolerance test (OGTT)
were measured in accordance
with the WHO criteria [96].
• The most recent study from a
duplicate publication of the same
data will be considered.
• Only studies published in English
will be included.
• Studies with impaired glucose
tolerance (IGT) and impaired
fasting glucose (IFG) as outcome
measures will be excluded from
this study.
• Risk factor definitions that do not
correspond to the WHO criteria
will be excluded.
• Reviews, commentaries and
letters will be excluded.
• Studies that are rated as low
quality in the risk of bias
assessment will be excluded.
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Syntax of search terms and subject headings termin-
ologies will be adapted according to the requirements of
the individual databases (Additional file 1). According to
chosen databases, all saved search strategies may be rou-
tinely run for any new studies that might be added.
Statistical methods
Selection of studies
Final search results will be imported to Endnote X8 and
duplicates will be deleted. For multiple studies using a
single dataset, the most recent will be used. Titles and
abstracts will undergo a first stage of screening by two
reviewers. Full text of potentially eligible studies will be
obtained and screened for final inclusion (please see
Fig. 1). Two independent reviewers will screen for eligi-
bility and inclusion. A third independent author will be
consulted to reach consensus, should any disagreement
arise. At this third stage, reasons for exclusion studies
will be well recorded.
Data extraction, coding and management
Two reviewers will extract data directly from included
studies into a Microsoft Excel spreadsheet. Any incon-
sistencies will be resolved by consensus and, if necessary,
a third reviewer will be consulted. Extracted data will in-
clude authors, year of publication, type of publication,
response rates for both published and unpublished stud-
ies, study years and study design and risk factors (obes-
ity, BMI, physical inactivity, fruit and vegetable
consumption, urban, rural, age and psychosocial factors)
with T2DM as an outcome measure. Others include
study location (country/nation) and sample size, odds ra-
tio (OR), confidence interval (CI), mean and standard
deviation (SD).
Study quality and critical appraisal
Quality assessment
PRISMA, Critical Appraisal Skills Programme (CASP)
[97] and Newcastle-Ottawa Scale (NOS) [98] will be
used to determine for study quality using tools tailored
to each study design. Figure 1 depicts the PRISMA flow
chart.
Data analysis
All included studies will be summarised descriptively be-
fore carrying out statistical analyses with Comprehensive
Meta-Analysis (CMA) version 2 software. The analysis
will synthesise the evidence to provide a summary of
pooled measure of association between one or more risk
factors and T2DM. The available measure of association
will determine the method of collapsing and the metric
that best fits. Thus, if correlation coefficients are used,
other statistical measures will be converted to correl-
ation coefficients and unadjusted odds ratios converted
to correlation coefficients. Statistical measures of associ-
ation between risk factors and T2DM may include re-
gression coefficients with SD, OR, and dichotomous
measures such as the χ2 test. Additionally, CMA soft-
ware will be used to convert standardised means. We
will also report two-tailed 95% CI, p values and ORs or
SDs, then use Cohen’s ‘d’ to calculate the effect sizes for
each risk factor. Both bivariate and multivariate associa-
tions between risk factors and T2DM will be retained;
however, only bivariate associations will be used in the
meta-analysis, given the challenges to meta-analysing ad-
justed data [99]. Associations from multivariate analyses
will be discussed in-text and possibly synthesised using
vote-counting methods (see [100]).
Longitudinal data will be included if data are reported
for multiple time points. If all included studies focus on
T2DM as an outcome, heterogeneity of the effect sizes
will then be assessed using the Q and I2 statistics [101].
To account for the variations in the sample sizes, the
CMA will be employed to calculate the weighted effect
sizes [102], i.e. ensuring that more weights are given to
the effects from larger samples. Considering the purpose
of the review is to generalise our findings, mixed effects
model will be used.
The mixed effect models will be used for moderator
analysis [103] as a more conservative approach to enable
the testing of differences between different moderator
levels (e.g. [102]). This model will ensure that differences
in study characteristics such as study designs, risk of
bias/study quality, and length of follow-up are well
tested. In the case where included studies report effect
size disaggregation, moderation analysis will be per-
formed on methodological variables based on the study
characteristics such as location (urban and rural) and re-
gions (Anglophone and Francophone). The moderation
analysis will also be used to compare associations from
multiple time (longitudinal data) and single time points
(cross-sectional data) as well as for different risk factors
and rank them accordingly.
Bias/quality assessment
Publication bias will be assessed through the steps out-
lined below.
For studies that focus on similar outcomes, hetero-
geneity of effect size among studies will be assessed
using Q and I2 statistics [101, 104]. Due to the antici-
pated heterogeneity described under the section titled
‘Heterogeneity in measured outcomes’, we can tenta-
tively assign a moderate I2 statistics of above 50%
cut-off heterogeneity.
(1) If more than ten studies report the same risk
factors, the symmetry of outcomes funnel plots will
be assessed.
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(2) Egger’s weighted regression method will be used [98].
(3) A failsafe number will be calculated to estimate the
number of unlocated studies with an average zero
effect size required to significantly change the
results.
Dealing with missing data
If we find that studies have not reported study designs,
methods, risk factors or outcomes, corresponding au-
thors will be contacted via email. If no further detail can
be obtained, it will be narrated descriptively and identi-
fied as a study limitation.
Discussion
This study aims to add to the extant literature by syn-
thesising the evidence on the association between modi-
fiable risk factors and T2DM in Africa and to provide a
reliable evidence base for policy makers and future
research.
Strength and limitations of the review
This is the first known systematic review and
meta-analysis of associations between TD2M and modi-
fiable risk factors in Africa. The strengths of this study
include stringent and strong adherence to the process of
conducting systematic review and meta-analyses and
quantitative research rigour, for example, stringent ad-
herence to the PRISMA checklist, including a transpar-
ent approach to searching, screening, reviewing,
selecting studies and data extraction [105]. The study
will ensure that the search area and inclusion criteria are
sufficiently complete to encompass a wide range of dia-
betes modifiable risk factors exposure measures and
T2DM. Although we will attempt to locate as many
Fig. 1 PRISMA flowchart for systematic review
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unpublished studies as possible, the findings may be sus-
ceptible to selective reporting. Furthermore, the fact that
only studies published in English language will be in-
cluded may constitute a limitation.
Dissemination plans
This systematic review and meta-analysis will form a
part of the primary author’s PhD thesis. The findings will
be disseminated through publications in peer-reviewed
journals, conferences and presentations.
Study registration
This systematic review and meta-analysis has been regis-
tered with PROSPERO—the International Prospective
Register of Systematic Reviews, registration number:
CRD42016043027.
Additional file
Additional file 1: Search terms and strategy. (DOCX 19 kb)
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